Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world safety and effectiveness of diazepam nasal spray in epilepsy
ChiCTR2500099144Phase 4Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of diazepam in epilepsy, sponsored by Beijing Tiantan Hospital. Primary endpoint: Adverse events within 28 days after administration of diazepam nasal spray. Started Mar 2025; status: recruiting.
02
Drugs
diazepam
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2500099144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099144.